These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7978795)

  • 21. The role of stromal cells in tumor metastasis: a new link.
    van den Hooff A
    Cancer Cells; 1991 May; 3(5):186-7. PubMed ID: 1679992
    [No Abstract]   [Full Text] [Related]  

  • 22. Tumor cell invasion, matrix metalloproteinases, and the dogma.
    Furcht LT; Skubitz AP; Fields GB
    Lab Invest; 1994 Jun; 70(6):781-3. PubMed ID: 8015282
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
    Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M
    Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of matrix metalloproteinases during extracellular matrix turnover.
    Corcoran ML; Kleiner DE; Stetler-Stevenson WG
    Adv Exp Med Biol; 1995; 385():151-9; discussion 179-84. PubMed ID: 8571826
    [No Abstract]   [Full Text] [Related]  

  • 25. Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis.
    Norman JT; Gatti L; Wilson PD; Lewis M
    Exp Nephrol; 1995; 3(2):88-9. PubMed ID: 7773643
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
    Alexander JP; Bradley JM; Gabourel JD; Acott TS
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinases. Novel targets for directed cancer therapy.
    Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
    Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma.
    Charous SJ; Stricklin GP; Nanney LB; Netterville JL; Burkey BB
    Ann Otol Rhinol Laryngol; 1997 Apr; 106(4):271-8. PubMed ID: 9109715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gelatinase A and APP.
    Miyazaki K; Funahashi K; Umeda M; Nakano A
    Nature; 1994 Apr; 368(6473):695-6. PubMed ID: 8179718
    [No Abstract]   [Full Text] [Related]  

  • 30. The matrix-degrading metalloproteinases.
    Matrisian LM
    Bioessays; 1992 Jul; 14(7):455-63. PubMed ID: 1445287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of matrix metalloproteinases in invasion and metastasis: biology, diagnosis and inhibitors.
    McDonnell S; Fingleton B
    Cytotechnology; 1993; 12(1-3):367-84. PubMed ID: 7764458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinases and their inhibitors in the nervous system: the good, the bad and the enigmatic.
    Campbell IL; Pagenstecher A
    Trends Neurosci; 1999 Jul; 22(7):285-7. PubMed ID: 10484748
    [No Abstract]   [Full Text] [Related]  

  • 33. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
    Nguyen Q; Willenbrock F; Cockett MI; O'Shea M; Docherty AJ; Murphy G
    Biochemistry; 1994 Mar; 33(8):2089-95. PubMed ID: 8117665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.
    Crawford HC; Matrisian LM
    Invasion Metastasis; 1994-1995; 14(1-6):234-45. PubMed ID: 7657516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor.
    Murphy G
    Matrix Suppl; 1992; 1():323-4. PubMed ID: 1480052
    [No Abstract]   [Full Text] [Related]  

  • 36. Matrix metalloproteinase inhibitors in the treatment of cancer.
    Brown PD
    Med Oncol; 1997 Mar; 14(1):1-10. PubMed ID: 9232605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of tissue inhibitor of matrix metalloproteinase expression.
    Overall CM
    Ann N Y Acad Sci; 1994 Sep; 732():51-64. PubMed ID: 7978851
    [No Abstract]   [Full Text] [Related]  

  • 38. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells.
    Li YY; McTiernan CF; Feldman AM
    Cardiovasc Res; 1999 Apr; 42(1):162-72. PubMed ID: 10435007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia.
    Urbanski SJ; Edwards DR; Hershfield N; Huchcroft SA; Shaffer E; Sutherland L; Kossakowska AE
    Diagn Mol Pathol; 1993 Jun; 2(2):81-9. PubMed ID: 8269281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.
    Kajita M; Itoh Y; Chiba T; Mori H; Okada A; Kinoh H; Seiki M
    J Cell Biol; 2001 May; 153(5):893-904. PubMed ID: 11381077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.